Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced that is has successfully completed the acquisition of Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, for an aggregate cash consideration up to $677 million on a fully diluted basis. The company said that the…